Israel Discount Bank of New York’s GSK GSK Stock Holding History

Israel Discount Bank of New York’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,488	Closed	-$321K	–	61
2024 Q1	$321K	Sell	7,488 -5,327	-42%	-$220K	0.4%	55
2023 Q4	$475K	Sell	12,815 -231	-2%	-$8.29K	0.37%	59
2023 Q3	$473K	Sell	13,046 -7	-0.1%	-$248	0.39%	52
2023 Q2	$465K	Sell	13,053 -2,372	-15%	-$85.1K	0.37%	58
2023 Q1	$549K	Sell	15,425 -235	-2%	-$8.22K	0.41%	55
2022 Q4	$550K	Buy	+15,660	New	+$522K	0.47%	53
2019 Q2	–	Sell	-124	Closed	-$6K	–	190
2019 Q1	$6K	Hold	124	–	–	﹤0.01%	396
2018 Q4	$6K	Hold	124	–	–	﹤0.01%	396
2018 Q3	$6K	Sell	124 -16	-11%	-$813	﹤0.01%	392
2018 Q2	$7K	Hold	140	–	–	﹤0.01%	387
2018 Q1	$7K	Hold	140	–	–	﹤0.01%	394
2017 Q4	$6K	Hold	140	–	–	﹤0.01%	402
2017 Q3	$7K	Buy	140 +20	+17%	+$1.01K	0.01%	398
2017 Q2	$6K	Hold	120	–	–	﹤0.01%	404
2017 Q1	$6K	Sell	120 -40	-25%	-$2.03K	﹤0.01%	410
2016 Q4	$8K	Buy	+160	New	+$7.9K	0.01%	432

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Israel Discount Bank of New York's GSK Position: Q2 2024 in Review

Israel Discount Bank of New York sold out of GSK (GSK) in Q2 2024, closing a stake of 7,488 shares — an estimated $321K sold.

Israel Discount Bank of New York first reported a position in GSK in Q4 2016 and held it in 16 quarters. The position peaked at $550K in Q4 2022. 885 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

Israel Discount Bank of New York reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
Israel Discount Bank of New York sold 7,488 GSK shares in Q2 2024, an estimated $321K.
Israel Discount Bank of New York first reported a position in GSK in Q4 2016 and held it in 16 quarters.
Israel Discount Bank of New York's GSK position peaked at $550K in Q4 2022.
885 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Israel Discount Bank of New York's 13F filing for Q2 2024, filed 13 Aug 2024.